BOSTON SCIENTIFIC CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.47 USD | +0.77% |
|
+8.76% | +26.84% |
| 05:08pm | UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating | MT |
| 04:28pm | Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Calendar
2024-05-02
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
72.91
USD
Average target price
78.18
USD
Spread / Average Target
+7.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.84% | 107B | |
| +8.16% | 220B | |
| +7.15% | 185B | |
| +11.14% | 133B | |
| -0.57% | 62.91B | |
| +16.17% | 53.34B | |
| -1.89% | 47.71B | |
| -1.70% | 40.29B | |
| +10.31% | 39.57B | |
| +6.27% | 26.99B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- JPMorgan Adjusts Price Target for Boston Scientific to $48 From $50, Maintains Overweight Rating
